2017
DOI: 10.1186/s12879-017-2395-8
|View full text |Cite
|
Sign up to set email alerts
|

Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania

Abstract: BackgroundThe spread of Extended Spectrum β-lactamases (ESBLs) among Enterobacteriaceae and other Gram-Negative pathogens in the community and hospitals represents a major challenge to combat infections. We conducted a study to assess the prevalence and genetic makeup of ESBL-type resistance in bacterial isolates causing community- and hospital-acquired urinary tract infections.MethodsA total of 172 isolates of Enterobacteriaceae were collected in Dar es Salaam, Tanzania, from patients who met criteria of comm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
33
1
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(41 citation statements)
references
References 26 publications
5
33
1
2
Order By: Relevance
“…26 In contrast to our study, a lower ESβL UTI prevalence was detected in other studies, in Dar es Salaam hospital, Tanzania (over 6 months period), and Marrakech University Hospital, Morocco (27% and 4.5%, respectively), between 2010 and 2012. 6,27 In Saudi Arabia and Tanzania, a higher frequency of ESβL-induced UTIs was found to be hospitalacquired compared with community-acquired infections (67% and 64%, respectively). 6,28 The high frequency of ESβL, especially among community-acquired UTIs, in our study is Extended-spectrum β-lactamase isolates were extremely resistant to cefepime and amoxicillin-clavulanic acid, and susceptible to carbapenems.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…26 In contrast to our study, a lower ESβL UTI prevalence was detected in other studies, in Dar es Salaam hospital, Tanzania (over 6 months period), and Marrakech University Hospital, Morocco (27% and 4.5%, respectively), between 2010 and 2012. 6,27 In Saudi Arabia and Tanzania, a higher frequency of ESβL-induced UTIs was found to be hospitalacquired compared with community-acquired infections (67% and 64%, respectively). 6,28 The high frequency of ESβL, especially among community-acquired UTIs, in our study is Extended-spectrum β-lactamase isolates were extremely resistant to cefepime and amoxicillin-clavulanic acid, and susceptible to carbapenems.…”
Section: Discussionmentioning
confidence: 99%
“…3 The spread of extended-spectrum β-lactamase (ESβL) Enterobacteriaceae UTI is increasing worldwide. 4,5 Although most of the ESβL producers are isolated from hospitalacquired UTIs, 6,7 a higher rate was screened by Nisha et al 8 and Djuikoue et al 9 from community-acquired UTIs. Escherichia coli and Klebsiella pneumoniae are the most predominant ESβL Enterobacteriaceae in the clinical setting; this has contributed to their beneficial value in estimating the prevalence of ESβL producers among different infections.…”
Section: Introductionmentioning
confidence: 99%
“…In all countries the origin was faecal (except Tunisia, with mastitis also). All types of descriptions presented in these 5 countries for E-ESBL in cattle also present reports in humans (Abbassi et al, 2008;Iroha et al, 2012;Manyahi et al, 2017;Ouedraogo et al, 2016).…”
Section: Africamentioning
confidence: 97%
“…Injudicious use of ceftriaxone may contribute to the high burden of AMR, including nosocomial infections with extended spectrum beta lactamase (ESBL)-producing Enterobacteriaceae, and complicate empirical treatment of severe bacterial infections. In view of the high prevalence of colonization and infections with ESBL positive Enterobacteriaceae in Tanzanian hospitals [21][22][23][24], increasing use of carbapenems in the future can be anticipated. In an attempt to limit empiric carbapenem use, the Tanzanian National Health Insurance Fund (NHIF) implemented a policy in July 2016 that limits carbapenem coverage to infections with a positive bacterial culture and sensitivity [25].…”
Section: Discussionmentioning
confidence: 99%